Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.

about

VEGFB-VEGFR1 ameliorates Ang II-induced cardiomyocyte hypertrophy through Ca(2+) -mediated PKG I pathway.Soluble Epoxide Hydrolase Inhibition Protected against Angiotensin II-induced Adventitial Remodeling miR-133: A Suppressor of Cardiac Remodeling?

P2860

Q38695797-1EFFF79C-C14D-4ECA-B466-527EDDE520E3 Q41191530-E592B590-09F7-40D8-8D4A-B596D6CB8177 Q58769694-8FE5D5B4-6A1F-4D75-B67F-CC4B8F6C5B84

P2860

Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.

Item

http://www.wikidata.org/entity/Q52147501

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca

@nl

Aspirin Attenuates Angiotensin ...... neurin-NFAT Signaling Pathway.

@en

type

Item

label

Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca

@nl

Aspirin Attenuates Angiotensin ...... neurin-NFAT Signaling Pathway.

@en

prefLabel

Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca

@nl

Aspirin Attenuates Angiotensin ...... neurin-NFAT Signaling Pathway.

@en

P1476

Aspirin Attenuates Angiotensin ...... neurin-NFAT Signaling Pathway.

@en

P2093

Hongfeng Zhou

http://www.w3.org/2001/XMLSchema#string

Lan Zhang

http://www.w3.org/2001/XMLSchema#string

Li Wei

http://www.w3.org/2001/XMLSchema#string

Xiaoqiu Dong

http://www.w3.org/2001/XMLSchema#string

Xiaoyun Wang

http://www.w3.org/2001/XMLSchema#string

Zheyu Yin

http://www.w3.org/2001/XMLSchema#string

P2860

PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling

Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6

Inhibition of cardiac hypertrophy by triflusal (4-trifluoromethyl derivative of salicylate) and its active metabolite

Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity

Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells

Inhibition of angiotensin II-induced cardiac hypertrophy and associated ventricular arrhythmias by a p21 activated kinase 1 bioactive peptide.

Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis.

Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy

Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy?

Cardiac hypertrophy: a risk factor for QT-prolongation and cardiac sudden death.

P304

21-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1755-5922.12164

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26506219

http://www.w3.org/2001/XMLSchema#string

P921

aspirin

Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.

about

P2860

P2860

Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921